42368-92-3

Upstream product

• 89-84-9 2',4'-dihydroxy-4-acetophenone 
• 23866-72-0 ethyl 7-hydroxy-4-oxo-4H-chromen-2-carboxylate 
• 40786-69-4 1-(2,4-dihydroxy-3-propylphenyl)ethanone 
• 95-92-1 oxalic acid diethyl ester 

Downstream Products

• 41432-82-0 7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid 
• 40785-97-5 7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-2-hydroxypropoxy]-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid 
• 96566-50-6 6-Acetyl-7-[5-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-pentyloxy]-8-propyl-chroman-2-carboxylic acid ethyl ester 
• 156005-67-3 7-{3-[4-((Z)-3-Dimethylamino-acryloyl)-2-ethyl-5-hydroxy-phenoxy]-propoxy}-8-propyl-chroman-2-carboxylic acid ethyl ester 
• 156005-28-6 3,4-dihydro-8-propyl-7-<<3-<2-ethyl-5-hydroxy-4-<3-(dimethylamino)-1-oxo-2-propenyl>phenoxy>propyl>oxy>-2H-1-benzopyran-2-carboxylic acid 
• 155219-34-4 3,4-dihydro-8-propyl-7-<<3-(4-acetyl-2-ethyl-5-hydroxyphenoxy)propyl>oxy>-2H-1-benzopyran-2-carboxylic acid ethyl ester 
• 99453-86-8 2-carboethoxy-7-[5-(2-n-propyl-3-hydroxy-4-acetylphenoxy)pentoxy]-8-n-propylchromone 

Relevant academic research and scientific papers

QUINOLINYL-BENZOPYRAN DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4

This invention relates to certain quinolinyl-benzopyran compounds and their use as valuable pharmaceutical agents, particularly as lipoxygenase inhibitors and/or leukotriene antagonists and/or mediator release inhibitors possessing anti-inflammatory and anti-allergic properties.

QUINOLINYL-CHROMONE DERIVATIVES AND USE FOR TREATMENT OF HYPERSENSITIVE AILMENTS

This invention relates to certain quinolinyl-chromone compounds and their use as valuable pharmaceutical agents, particularly as lipoxygenase inhibitors and/or leukotriene antagonists possessing anti-inflammatory and anti-allergic properties.

Novel benzopyran derivatives

7-[3-(4-Acetyl-3-hydroxy-6-iodo-2-propylphenoxy)-2-hydroxypropoxy]-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid and its pharmaceutically acceptable salts are employed as antagonists of SRS-A (the slow reacting substance of anaphylaxis) in the treatmen